Mycophenolate mofetil as a rescue therapy for autoimmune hepatitis patients who are not responsive to standard therapy

2011 ◽  
Vol 5 (4) ◽  
pp. 517-522 ◽  
Author(s):  
Hind I Fallatah ◽  
Hisham O Akbar
Keyword(s):  
Mycophenolate Mofetil ◽  
Autoimmune Hepatitis ◽  
Standard Therapy ◽  
Rescue Therapy

scholarly journals Mycophenolate Mofetil for the Treatment of Autoimmune Hepatitis in Patients Refractory to Standard Therapy

2004 ◽  
Vol 18 (5) ◽  
pp. 321-326 ◽  
Author(s):  
Shane M Devlin ◽  
Mark G Swain ◽  
Stefan J Urbanski ◽  
Kelly W Burak
Keyword(s):  
Mycophenolate Mofetil ◽  
Autoimmune Hepatitis ◽  
Alanine Aminotransferase ◽  
Standard Therapy ◽  
Conventional Treatment ◽  
Case Series ◽  
Therapeutic Options ◽  
Sparing Effect ◽  
Histological Remission ◽  
Steroid Sparing

There are limited therapeutic options available for patients with autoimmune hepatitis in whom conventional treatment fails. A case series of five patients unresponsive to or unable to take azathioprine, 6-mercaptopurine or corticosteroids who were treated with mycophenolate mofetil (MMF) is reported. While on MMF, alanine aminotransferase normalized or remained normal in all patients. MMF had a steroid-sparing effect and histological remission was demonstrated in one patient after seven months of MMF. One patient experienced an uncomplicated episode of pyelonephritis. In conclusion, MMF can effectively induce and maintain remission in refractory autoimmune hepatitis patients.

scholarly journals Editorial: tailoring mycophenolate mofetil rescue therapy for success in autoimmune hepatitis-authors' reply

2019 ◽  
Vol 49 (11) ◽  
pp. 1450-1451
Author(s):  
Amanda J. Nicoll ◽  
Stuart K. Roberts ◽  
Simone I. Strasser ◽  
Keyword(s):  
Mycophenolate Mofetil ◽  
Autoimmune Hepatitis ◽  
Rescue Therapy

Mycophenolate mofetil treatment in patients with autoimmune hepatitis failing standard therapy with prednisolone and azathioprine

2019 ◽  
Vol 51 (2) ◽  
pp. 253-257 ◽  
Author(s):  
Georgios Giannakopoulos ◽  
Hans Verbaan ◽  
Inga-Lill Friis-Liby ◽  
Per Sangfelt ◽  
Nils Nyhlin ◽  
...  
Keyword(s):  
Mycophenolate Mofetil ◽  
Autoimmune Hepatitis ◽  
Standard Therapy

Efficacy and Safety of Mycophenolate Mofetil in Patients With Autoimmune Hepatitis and Suboptimal Outcomes After Standard Therapy

2018 ◽  
Vol 16 (2) ◽  
pp. 268-277 ◽  
Author(s):  
Stuart K. Roberts ◽  
Ricky Lim ◽  
Simone Strasser ◽  
Amanda Nicoll ◽  
Alessia Gazzola ◽  
...  
Keyword(s):  
Mycophenolate Mofetil ◽  
Autoimmune Hepatitis ◽  
Standard Therapy ◽  
Efficacy And Safety

Low dose tacrolimus for the treatment of autoimmune hepatitis resistant to standard therapy

2003 ◽  
Vol 124 (4) ◽  
pp. A785 ◽  
Author(s):  
Sajid Jalil ◽  
Ahmet Gurakar ◽  
Harlan Wright ◽  
Ted Bader ◽  
Anthony Sebastian ◽  
...  
Keyword(s):  
Autoimmune Hepatitis ◽  
Standard Therapy ◽  
Low Dose

scholarly journals Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis

2017 ◽  
Vol 15 (12) ◽  
pp. 1950-1956.e1 ◽  
Author(s):  
Cumali Efe ◽  
Hannes Hagström ◽  
Henriette Ytting ◽  
Rahima A. Bhanji ◽  
Niklas F. Müller ◽  
...  
Keyword(s):  
Mycophenolate Mofetil ◽  
Autoimmune Hepatitis ◽  
Second Line ◽  
Efficacy And Safety ◽  
Second Line Therapy ◽  
Line Therapy

Comparison of mycophenolate mofetil with standard treatment for autoimmune hepatitis

2019 ◽  
Vol 31 (7) ◽  
pp. 873-877 ◽  
Author(s):  
Zhen-Jun Yu ◽  
Lu-Lu Zhang ◽  
Ting-Ting Huang ◽  
Jian-Sheng Zhu ◽  
Ze-Bao He
Keyword(s):  
Mycophenolate Mofetil ◽  
Autoimmune Hepatitis ◽  
Standard Treatment
Sign in / Sign up

Export Citation Format

Share Document